Virax Biolabs Group Ltd (VRAX) Inventory (2021 - 2025)

Virax Biolabs (VRAX) has 4 years of Inventory data on file, last reported at $94675.0 in Q1 2025.

• In Q1 2025, Inventory rose 56.79% year-over-year to $94675.0; the TTM figure through Mar 2025 stood at $94675.0 (up 56.79% YoY), while the FY2025 annual figure was $94675.0, up 56.79% from the prior year.
• Inventory grew to $94675.0 in Q1 2025, from $60383.0 in the prior quarter.
• Across five years, Inventory topped out at $94675.0 in Q1 2025 and bottomed at $20951.0 in Q1 2022.
• A 4-year average of $49270.2 and a median of $40727.5 in 2021 frame the typical range for Inventory.
• Annual changes were most pronounced in 2022 — Inventory decreased 0.57% — and 2025, when it soared 56.79%.
• Year by year, Inventory stood at $21072.0 in 2021, then fell by 0.57% to $20951.0 in 2022, then soared by 188.21% to $60383.0 in 2024, then soared by 56.79% to $94675.0 in 2025.
• The last three Inventory figures came in at $94675.0 (Q1 2025), $60383.0 (Q1 2024), and $20951.0 (Q1 2022), per Business Quant data.

Peer Comparison